Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis-Reference-Cited by-同舟云学术

Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis

Published:2023-08 Issue: Volume:Volume 17 Page:1923-1933
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Lin Yu-Ting^ORCID,Will Tamara,Wickham Charlotte^ORCID,Boeree Petra^ORCID,Jack Dominic,Keiser Matthew

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference12 articles.

1. Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis

2. Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

3. Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study

4. An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart®

5. DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In situ formed aldehyde-modified hyaluronic acid hydrogel with polyelectrolyte complexes of aldehyde-modified chondroitin sulfate and gelatin: An approach for minocycline delivery;Carbohydrate Polymers;2024-11

2. Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study;Frontiers in Neurology;2023-11-28